NBIX

Neurocrine Biosciences
NBIX

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$10.61B
EV
$10.03B
Shares Outstanding
99.99M
Beta
0.33

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$156.37
P/E 2025E
17.61x
P/Revenue 2025E
3.99x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Neurocrine Biosciences, Inc.

gainify
NBIX

Neurocrine Biosciences, Inc.

NBIX

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company’s products include INGREZZA for tardive dyskinesia and chorea associate...

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Gano, Kyle

Employees

1,800

IPO Date

1996-05-23

Headquarters

12780 El Camino Real, San Diego, California, 92130, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved